SE9301290D0 - Anvaendning av en somatostatinanalog - Google Patents
Anvaendning av en somatostatinanalogInfo
- Publication number
- SE9301290D0 SE9301290D0 SE19939301290A SE9301290A SE9301290D0 SE 9301290 D0 SE9301290 D0 SE 9301290D0 SE 19939301290 A SE19939301290 A SE 19939301290A SE 9301290 A SE9301290 A SE 9301290A SE 9301290 D0 SE9301290 D0 SE 9301290D0
- Authority
- SE
- Sweden
- Prior art keywords
- somatostatin analogue
- pharmaceutical composition
- somatostatin
- analogue
- administered
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/16—Somatostatin; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878716324A GB8716324D0 (en) | 1987-07-10 | 1987-07-10 | Organic compounds |
GB878716326A GB8716326D0 (en) | 1987-07-10 | 1987-07-10 | Organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9301290A0 SE9301290A0 (sv) | 1993-04-20 |
SE9301290D0 true SE9301290D0 (sv) | 1993-04-20 |
Family
ID=26292476
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8802569A SE503191C2 (sv) | 1987-07-10 | 1988-07-08 | Farmaceutisk komposition innehållande en somatostatinanalog samt användning därav |
SE19939301290A SE9301290D0 (sv) | 1987-07-10 | 1993-04-20 | Anvaendning av en somatostatinanalog |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8802569A SE503191C2 (sv) | 1987-07-10 | 1988-07-08 | Farmaceutisk komposition innehållande en somatostatinanalog samt användning därav |
Country Status (27)
Country | Link |
---|---|
US (2) | US5753618A (sv) |
JP (1) | JP2578477B2 (sv) |
AU (1) | AU618270B2 (sv) |
BE (1) | BE1001079A4 (sv) |
CA (1) | CA1328402C (sv) |
CH (1) | CH677449A5 (sv) |
CS (1) | CS411591A3 (sv) |
CY (2) | CY1631A (sv) |
DE (2) | DE3845000C2 (sv) |
DK (2) | DK174125B1 (sv) |
ES (1) | ES2010561A6 (sv) |
FI (1) | FI93308C (sv) |
FR (1) | FR2617714B1 (sv) |
GB (1) | GB2208200B (sv) |
GR (1) | GR1000172B (sv) |
HK (1) | HK16492A (sv) |
HU (1) | HU203480B (sv) |
IE (1) | IE61908B1 (sv) |
IL (1) | IL87044A0 (sv) |
LU (1) | LU87268A1 (sv) |
MY (2) | MY109309A (sv) |
NL (1) | NL194823C (sv) |
NO (1) | NO179359C (sv) |
NZ (1) | NZ225340A (sv) |
PT (1) | PT87957B (sv) |
SE (2) | SE503191C2 (sv) |
SG (1) | SG3692G (sv) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8813339D0 (en) * | 1988-06-06 | 1988-07-13 | Sandoz Ltd | Improvements in/relating to organic compounds |
US5538739A (en) * | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
PH30995A (en) * | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
US5626945A (en) * | 1993-09-28 | 1997-05-06 | International Paper Company | Repulpable, water repellant paperboard |
US6355613B1 (en) * | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
WO1998008528A1 (en) | 1996-08-30 | 1998-03-05 | Biomeasure Incorporated | Method of inhibiting fibrosis with a somatostatin agonist |
ES2167189B1 (es) * | 1999-12-17 | 2003-04-01 | Lipotec Sa | Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos |
US6316414B1 (en) | 2000-07-31 | 2001-11-13 | Dabur Research Foundation | Somatostatin analogs for the treatment of cancer |
EP2062914B1 (en) * | 2001-06-08 | 2014-05-07 | Ipsen Pharma | Somatostatin-dopamine chimeric analogs |
TWI287986B (en) * | 2001-12-13 | 2007-10-11 | Novartis Ag | Use of Epothilones for the treatment of the carcinoid syndrome |
US20030207811A1 (en) * | 2002-05-03 | 2003-11-06 | Schrier Bruce K. | Method of treating retinopathy of prematurity using somatostatin analogs |
SI1787658T1 (sl) | 2005-11-10 | 2012-07-31 | Chemi Spa | Formulacije z trajnim sproščanjem somatostatin analognih inhibitorjev rastnega hormona |
JP2009532346A (ja) * | 2006-03-31 | 2009-09-10 | イラスマス・ユニバーシティ・メディカル・センター・ロッテルダム | 腫瘍増殖制御のための新規組成物 |
US20100160275A1 (en) * | 2006-09-26 | 2010-06-24 | Lee Eva Y H P | Methods and compositions for cancer prevention and treatment |
US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
US20090325863A1 (en) * | 2008-06-13 | 2009-12-31 | Kleinberg David L | Somatostatin analogs and IGF-I inhibition for breast cancer prevention |
GB201016436D0 (en) | 2010-09-30 | 2010-11-17 | Q Chip Ltd | Method of making solid beads |
GB201016433D0 (en) | 2010-09-30 | 2010-11-17 | Q Chip Ltd | Apparatus and method for making solid beads |
WO2012074559A2 (en) * | 2010-12-02 | 2012-06-07 | New York University | Treatment of non-proliferative cystic disease |
RU2652605C2 (ru) * | 2011-06-02 | 2018-04-27 | Зе Реджентс Оф Зе Юниверсити Оф Калифорния | Блокада воспалительных протеаз тета-дефензинами |
TWI523863B (zh) | 2012-11-01 | 2016-03-01 | 艾普森藥品公司 | 體抑素-多巴胺嵌合體類似物 |
WO2014070965A2 (en) | 2012-11-01 | 2014-05-08 | Ipsen Pharma S.A.S | Somatostatin analogs and dimers thereof |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH621770A5 (en) * | 1976-02-23 | 1981-02-27 | Sandoz Ag | Process for the preparation of novel peptide compounds |
IE47421B1 (en) * | 1977-06-08 | 1984-03-07 | Merck & Co Inc | Somatostatin analogs,process for their preparation and pharmaceutical compositions containing them |
LU78191A1 (de) * | 1977-09-28 | 1979-05-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen cyclopeptiden |
US4328214A (en) * | 1979-07-04 | 1982-05-04 | Ciba-Geigy Corporation | Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture |
US4900730A (en) * | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
JPS57188526A (en) * | 1981-05-14 | 1982-11-19 | Takeda Chem Ind Ltd | Peptide-containing pharmaceutical preparation |
US4374060A (en) * | 1981-07-15 | 1983-02-15 | Merck & Co., Inc. | Process for the preparation of cyclic hexapeptide |
EP0083305B1 (de) * | 1981-12-24 | 1985-07-10 | Ciba-Geigy Ag | Cyclische Octapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung |
US4522813A (en) * | 1983-10-27 | 1985-06-11 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
NL8503426A (nl) * | 1984-12-24 | 1986-07-16 | Sandoz Ag | 8alfa-acylamino-ergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten. |
US4650787A (en) * | 1985-04-25 | 1987-03-17 | Schally Andrew Victor | Biologically active octapeptides |
US4725577A (en) * | 1985-04-25 | 1988-02-16 | Administrators Of The Tulane Educational Fund | Biologically active lysine containing octapeptides |
ZW14486A1 (en) * | 1985-07-29 | 1986-10-22 | Smithkline Beckman Corp | Pharmaceutical dosage unit |
GR862206B (en) * | 1985-09-12 | 1986-12-31 | Univ Tulane | Therapeutic somatostatin analogs |
JPH085913B2 (ja) * | 1985-09-12 | 1996-01-24 | ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド | 治療用ソマトスタチン同族体 |
HU198626B (en) * | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
NL194729C (nl) * | 1986-10-13 | 2003-01-07 | Novartis Ag | Werkwijze voor de bereiding van peptidealcoholen via vaste fase. |
AU639371B2 (en) * | 1987-07-10 | 1993-07-22 | Novartis Ag | Method of treating breast cancer |
US5187150A (en) * | 1987-10-14 | 1993-02-16 | Debiopharm S.A. | Polyester-based composition for the controlled release of polypeptide medicinal substances |
AU2284588A (en) * | 1988-09-26 | 1990-03-29 | Sandoz Ltd. | Improvements in or relating to organic compounds |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
US5384309A (en) * | 1989-07-17 | 1995-01-24 | Genentech, Inc. | Cyclized peptides and their use as platelet aggregation inhibitors |
JPH0532696A (ja) * | 1990-09-28 | 1993-02-09 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
-
1988
- 1988-07-04 DE DE3845000A patent/DE3845000C2/de not_active Expired - Lifetime
- 1988-07-04 DE DE3822557A patent/DE3822557C2/de not_active Expired - Lifetime
- 1988-07-05 CH CH2556/88A patent/CH677449A5/de not_active IP Right Cessation
- 1988-07-06 GB GB8816024A patent/GB2208200B/en not_active Expired - Lifetime
- 1988-07-07 MY MYPI93000569A patent/MY109309A/en unknown
- 1988-07-07 MY MYPI88000750A patent/MY103746A/en unknown
- 1988-07-08 NO NO883054A patent/NO179359C/no not_active IP Right Cessation
- 1988-07-08 SE SE8802569A patent/SE503191C2/sv not_active IP Right Cessation
- 1988-07-08 HU HU883604A patent/HU203480B/hu unknown
- 1988-07-08 CA CA000571592A patent/CA1328402C/en not_active Expired - Lifetime
- 1988-07-08 IL IL87044A patent/IL87044A0/xx not_active IP Right Cessation
- 1988-07-08 NL NL8801734A patent/NL194823C/nl not_active IP Right Cessation
- 1988-07-08 IE IE209188A patent/IE61908B1/en not_active IP Right Cessation
- 1988-07-08 ES ES8802161A patent/ES2010561A6/es not_active Expired
- 1988-07-08 PT PT87957A patent/PT87957B/pt not_active IP Right Cessation
- 1988-07-08 LU LU87268A patent/LU87268A1/fr unknown
- 1988-07-08 FI FI883261A patent/FI93308C/sv active IP Right Grant
- 1988-07-08 NZ NZ225340A patent/NZ225340A/en unknown
- 1988-07-08 AU AU18893/88A patent/AU618270B2/en not_active Expired
- 1988-07-08 GR GR880100458A patent/GR1000172B/el not_active IP Right Cessation
- 1988-07-08 DK DK198803854A patent/DK174125B1/da not_active IP Right Cessation
- 1988-07-08 FR FR888809439A patent/FR2617714B1/fr not_active Expired - Lifetime
- 1988-07-09 JP JP63171703A patent/JP2578477B2/ja not_active Expired - Lifetime
- 1988-07-11 BE BE8800803A patent/BE1001079A4/fr not_active IP Right Cessation
-
1991
- 1991-12-27 CS CS914115A patent/CS411591A3/cs unknown
-
1992
- 1992-01-13 SG SG36/92A patent/SG3692G/en unknown
- 1992-02-27 HK HK164/92A patent/HK16492A/xx not_active IP Right Cessation
- 1992-07-10 CY CY1631A patent/CY1631A/xx unknown
- 1992-07-10 CY CY1632A patent/CY1632A/xx unknown
-
1993
- 1993-04-20 SE SE19939301290A patent/SE9301290D0/sv not_active Application Discontinuation
-
1995
- 1995-06-06 US US08/471,706 patent/US5753618A/en not_active Expired - Lifetime
-
1998
- 1998-02-11 US US09/022,079 patent/US6066616A/en not_active Expired - Fee Related
-
2001
- 2001-04-04 DK DK200100558A patent/DK174476B1/da not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9301290D0 (sv) | Anvaendning av en somatostatinanalog | |
CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
ES2055911T3 (es) | Compuesto farmaceutico adelgazante. | |
ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
IL102848A0 (en) | Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them | |
ATE66614T1 (de) | Insulinzubereitung fuer nicht-parenterale verabreichung. | |
UA26855C2 (uk) | Фармацевтичhа композиція, яка регулює гематопоез | |
DE69003392D1 (de) | Dosisform zur oralen verabreichung des hypoglykämischen glipizids. | |
DE68910159D1 (de) | Dosierform für Verabreichung in der Humanmedizin. | |
DK420385D0 (da) | Antioestrogent laegemiddel til perkutan indgift | |
LV10954A (lv) | Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija | |
ATE74006T1 (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken. | |
DE3650358D1 (de) | Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis. | |
ES478967A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7. | |
GB1395090A (en) | Stabilized hormone compositions | |
PH27446A (en) | Compound with gastric acid inhibitory effect | |
BR8008818A (pt) | Peptidos farmacologicamente ativos e medicamentos contendo os mesmos | |
DE3861494D1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
DE59108104D1 (de) | Arzneimittel enthaltend cd14 | |
DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
AU5198686A (en) | Praparat zur intramuskularen injektion von medikamenten vitaminen oder impfstoffen | |
GB1507643A (en) | 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis | |
DE3686536D1 (de) | Oxytocin und antigestagen zur einleitung der geburt. | |
GB1330993A (en) | Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 9301290-4 |